Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305

By sjmartinez • March 12, 2024

Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305. Int J Mol Sci. 2024 Feb 23;25(5):2579. doi: 10.3390/ijms25052579. Erratum for: Int J Mol Sci. 2017 Nov 02;18(11): PMID: 38474325.

Tags: Endocrinology, General Internal Medicine, Hematology/Oncology, King Drew Med Ctr, Publications

Related Posts

Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones

Shay JES, Chi F, Tzouanas CN, Han S, Zhang X, Ten Hoeve J, Williams KJ, Neptun S, Sever T, Fuentes I, Bhatia SN, Calibasi-Kocal G,[...]

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center

Tavares M, Khoshbin K, Solorzano W, Scarlett L, Santana C, Lopez R, Villanueva GP, Escobar B, Mangual KS, Pavlish C, Bush NJ, Moin T, Everett[...]

Enhancing mental and physical health of women through engagement and retention (EMPOWER) 3.0 QUERI: study protocol for a cluster-randomized hybrid type 3 implementation-effectiveness trial

Hamilton AB, Farmer MM, Bean-Mayberry B, Moin T, Lang A, Adams L, Chanfreau C, Fenwick K, Canelo I, Oberman R, Finley EP; EMPOWER 3.0 QUERI[...]